Perimenopause: The Silent Heart Risk Ignored

Heart disease kills more women than all cancers combined, yet most women sail through perimenopause without anyone warning them that their arteries are quietly changing course.

Quick Take

Cholesterol, blood pressure, and arterial plaque accumulation all accelerate during perimenopause, before periods even stop.
The Study of Women’s Health Across the Nation links the menopause transition to increases in LDL cholesterol, metabolic syndrome risk, and measurable stiffening of blood vessels.
Nocturnal hot flashes clustered in the second half of the night disrupt the sleep phase most associated with cardiovascular repair, adding another layer of risk.
Women who reach menopause before age 45 face a measurably higher risk of arterial hypertension and cardiovascular disease later in life.

The Risk Window Most Doctors Never Mention

The conversation about women and heart disease has traditionally started at postmenopause, if it started at all. That framing is now being challenged by a growing body of evidence pointing earlier, to perimenopause, the transitional years before periods stop. University of Colorado Anschutz researcher Nanette Santoro, MD, puts it plainly: “There are sudden increases in heart disease risks during this transition, right before a woman’s estrogen significantly declines,” citing steeper rises in cholesterol, blood pressure, and carotid artery plaque accumulation as the specific culprits. ^[1]

What makes this window so medically significant is timing. Estrogen does not simply switch off at menopause. Levels begin declining during perimenopause, and the British Heart Foundation explains the mechanism directly: as estrogen falls, fat builds up in arteries, raising the risk of coronary heart disease, heart attack, and stroke. ^[2] The damage, in other words, starts accumulating years before most women or their doctors are watching for it.

What the Long-Term Cohort Data Actually Shows

The Study of Women’s Health Across the Nation, one of the most comprehensive longitudinal studies of midlife women ever conducted, documents increases in LDL cholesterol, rising metabolic syndrome risk, and adverse changes in blood vessel structure during the menopause transition. ^[3] Cardiologist Samar El Khoudary, whose work is cited by the American Heart Association (AHA), describes the vascular picture with precision: arteries become more vulnerable to disease, growing thicker and stiffer, and “all of those changes accelerate during menopause.” ^[4] That acceleration is the crux of the argument for treating perimenopause as a prevention window, not merely a symptom period.

A peer-reviewed analysis published in PubMed Central frames the stakes in population terms: women develop heart disease later than men because of estrogen’s protective effects during reproductive years, but once they enter menopause, that protection erodes and risk climbs. ^[7] The same review emphasizes that early intervention strategies should be implemented during this window, not after cardiovascular markers have already worsened. The evidence is directionally consistent across multiple institutions and research groups, even if the precise magnitude of risk attributable to hormone change versus age and lifestyle factors remains an open scientific question.

Hot Flashes at 3 AM Are Not Just Uncomfortable

The Menopause Society has flagged a detail that deserves far more attention than it receives. Hot flashes are not evenly distributed across the night. Research shows more nocturnal hot flashes occur during the second half of the night, precisely when rapid eye movement sleep is most concentrated, and disruption during that phase carries a greater chance of increasing cardiovascular risk. ^[5] This is not a minor footnote. Sleep quality is a recognized cardiovascular risk factor, and if perimenopausal women are losing their most restorative sleep hours repeatedly, the cardiac implications compound over time.

Women in perimenopause are sometimes treated for anxiety or depression without anyone first checking hormones, sleep, metabolic health, stress load, or menopause symptoms. Hormonal changes can profoundly affect mood and cognition. If you are in your 40’s, be informed, ask for a…

— AnaBeckCoaching (@AnaBeck95444) May 15, 2026

Women who experience early menopause, defined as before age 45, face an even steeper climb. Johns Hopkins Medicine reports that these women experience more cardiovascular health issues later in life, ^[6] and the PubMed Central review specifically ties early menopause to higher risk of arterial hypertension. ^[7] The biology here is not subtle. An abrupt or accelerated loss of estrogen appears to leave the cardiovascular system more exposed, and that exposure compounds with every passing year if it goes unaddressed.

Real Signal, Incomplete Proof, and Why It Still Matters

The honest scientific picture is that the signal is real but the causal chain is not fully untangled. Most available evidence relies on surrogate markers, LDL levels, blood pressure readings, carotid plaque measurements, arterial stiffness scores, rather than hard outcomes like heart attacks or strokes directly attributed to perimenopause. Researchers have not yet cleanly separated the hormone-transition effect from the effects of aging, weight changes, sleep disruption, and depression that often occur simultaneously. That is a legitimate limitation, and any responsible reading of this evidence should acknowledge it.

But limitations in proof are not the same as absence of risk. The AHA, Johns Hopkins Medicine, the Study of Women’s Health Across the Nation, and multiple published reviews all converge on the same practical conclusion: perimenopause is a critical cardiovascular window that has been systematically underrecognized in routine care. ^[4]^[6]^[3] Women deserve to know this before their arteries start keeping score.